 | • レポートコード：MRC2-11QY12798 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は腸チフスワクチンのグローバル市場について調査・分析したレポートです。種類別（経口タイプ、注射タイプ）市場規模、用途別（病院、研究所、製薬＆バイオテクノロジー企業、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別腸チフスワクチンの競争状況、市場シェア ・世界の腸チフスワクチン市場：種類別市場規模 2015年-2020年（経口タイプ、注射タイプ） ・世界の腸チフスワクチン市場：種類別市場規模予測 2021年-2026年（経口タイプ、注射タイプ） ・世界の腸チフスワクチン市場：用途別市場規模 2015年-2020年（病院、研究所、製薬＆バイオテクノロジー企業、その他） ・世界の腸チフスワクチン市場：用途別市場規模予測 2021年-2026年（病院、研究所、製薬＆バイオテクノロジー企業、その他） ・北米の腸チフスワクチン市場分析：米国、カナダ ・ヨーロッパの腸チフスワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの腸チフスワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の腸チフスワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの腸チフスワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Sanofi、Merck、GlaxoSmithKline、PaxVax、Actiza Pharmaceutical、Merit Pharmaceuticals、Bharat Biotec ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Typhoid Vaccine Market
The global Typhoid Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Typhoid Vaccine Scope and Market Size
Typhoid Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Typhoid Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Typhoid Vaccine market is segmented into
Oral Type
Injection Type
Segment by Application, the Typhoid Vaccine market is segmented into
Hospital
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
Regional and Country-level Analysis
The Typhoid Vaccine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Typhoid Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Typhoid Vaccine Market Share Analysis
Typhoid Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Typhoid Vaccine business, the date to enter into the Typhoid Vaccine market, Typhoid Vaccine product introduction, recent developments, etc.
The major vendors covered:
Sanofi
Merck
GlaxoSmithKline
PaxVax
Actiza Pharmaceutical
Merit Pharmaceuticals
Bharat Biotec
…
1 Study Coverage
1.1 Typhoid Vaccine Product Introduction
1.2 Market Segments
1.3 Key Typhoid Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Typhoid Vaccine Market Size Growth Rate by Type
1.4.2 Oral Type
1.4.3 Injection Type
1.5 Market by Application
1.5.1 Global Typhoid Vaccine Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Research & Academic Laboratories
1.5.4 Pharmaceutical & Biotechnology Companies
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Typhoid Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Typhoid Vaccine Revenue 2015-2026
2.1.2 Global Typhoid Vaccine Sales 2015-2026
2.2 Global Typhoid Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Typhoid Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Typhoid Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Typhoid Vaccine Competitor Landscape by Players
3.1 Typhoid Vaccine Sales by Manufacturers
3.1.1 Typhoid Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Typhoid Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Typhoid Vaccine Revenue by Manufacturers
3.2.1 Typhoid Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Typhoid Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Typhoid Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Typhoid Vaccine Revenue in 2019
3.2.5 Global Typhoid Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Typhoid Vaccine Price by Manufacturers
3.4 Typhoid Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Typhoid Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Typhoid Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Typhoid Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Typhoid Vaccine Market Size by Type (2015-2020)
4.1.1 Global Typhoid Vaccine Sales by Type (2015-2020)
4.1.2 Global Typhoid Vaccine Revenue by Type (2015-2020)
4.1.3 Typhoid Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Typhoid Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Typhoid Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Typhoid Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Typhoid Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Typhoid Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Typhoid Vaccine Market Size by Application (2015-2020)
5.1.1 Global Typhoid Vaccine Sales by Application (2015-2020)
5.1.2 Global Typhoid Vaccine Revenue by Application (2015-2020)
5.1.3 Typhoid Vaccine Price by Application (2015-2020)
5.2 Typhoid Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Typhoid Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Typhoid Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Typhoid Vaccine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Typhoid Vaccine by Country
6.1.1 North America Typhoid Vaccine Sales by Country
6.1.2 North America Typhoid Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Typhoid Vaccine Market Facts & Figures by Type
6.3 North America Typhoid Vaccine Market Facts & Figures by Application
7 Europe
7.1 Europe Typhoid Vaccine by Country
7.1.1 Europe Typhoid Vaccine Sales by Country
7.1.2 Europe Typhoid Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Typhoid Vaccine Market Facts & Figures by Type
7.3 Europe Typhoid Vaccine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Typhoid Vaccine by Region
8.1.1 Asia Pacific Typhoid Vaccine Sales by Region
8.1.2 Asia Pacific Typhoid Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Typhoid Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Typhoid Vaccine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Typhoid Vaccine by Country
9.1.1 Latin America Typhoid Vaccine Sales by Country
9.1.2 Latin America Typhoid Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Typhoid Vaccine Market Facts & Figures by Type
9.3 Central & South America Typhoid Vaccine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Typhoid Vaccine by Country
10.1.1 Middle East and Africa Typhoid Vaccine Sales by Country
10.1.2 Middle East and Africa Typhoid Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Typhoid Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Typhoid Vaccine Market Facts & Figures by Application
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description and Business Overview
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Typhoid Vaccine Products Offered
11.1.5 Sanofi Related Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description and Business Overview
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Typhoid Vaccine Products Offered
11.2.5 Merck Related Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Corporation Information
11.3.2 GlaxoSmithKline Description and Business Overview
11.3.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GlaxoSmithKline Typhoid Vaccine Products Offered
11.3.5 GlaxoSmithKline Related Developments
11.4 PaxVax
11.4.1 PaxVax Corporation Information
11.4.2 PaxVax Description and Business Overview
11.4.3 PaxVax Sales, Revenue and Gross Margin (2015-2020)
11.4.4 PaxVax Typhoid Vaccine Products Offered
11.4.5 PaxVax Related Developments
11.5 Actiza Pharmaceutical
11.5.1 Actiza Pharmaceutical Corporation Information
11.5.2 Actiza Pharmaceutical Description and Business Overview
11.5.3 Actiza Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Actiza Pharmaceutical Typhoid Vaccine Products Offered
11.5.5 Actiza Pharmaceutical Related Developments
11.6 Merit Pharmaceuticals
11.6.1 Merit Pharmaceuticals Corporation Information
11.6.2 Merit Pharmaceuticals Description and Business Overview
11.6.3 Merit Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Merit Pharmaceuticals Typhoid Vaccine Products Offered
11.6.5 Merit Pharmaceuticals Related Developments
11.7 Bharat Biotec
11.7.1 Bharat Biotec Corporation Information
11.7.2 Bharat Biotec Description and Business Overview
11.7.3 Bharat Biotec Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bharat Biotec Typhoid Vaccine Products Offered
11.7.5 Bharat Biotec Related Developments
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description and Business Overview
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Typhoid Vaccine Products Offered
11.1.5 Sanofi Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Typhoid Vaccine Market Estimates and Projections by Region
12.1.1 Global Typhoid Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Typhoid Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Typhoid Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Typhoid Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Typhoid Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Typhoid Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Typhoid Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Typhoid Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Typhoid Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Typhoid Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Typhoid Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Typhoid Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Typhoid Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Typhoid Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Typhoid Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Typhoid Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Typhoid Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Typhoid Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Typhoid Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Typhoid Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Typhoid Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Typhoid Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Typhoid Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Typhoid Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Typhoid Vaccine Market Segments
Table 2. Ranking of Global Top Typhoid Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Typhoid Vaccine Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Oral Type
Table 5. Major Manufacturers of Injection Type
Table 6. Global Typhoid Vaccine Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Typhoid Vaccine Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Typhoid Vaccine Sales by Regions 2015-2020 (K Units)
Table 9. Global Typhoid Vaccine Sales Market Share by Regions (2015-2020)
Table 10. Global Typhoid Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Typhoid Vaccine Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Typhoid Vaccine Sales Share by Manufacturers (2015-2020)
Table 13. Global Typhoid Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Typhoid Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Typhoid Vaccine as of 2019)
Table 15. Typhoid Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Typhoid Vaccine Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Typhoid Vaccine Price (2015-2020) (USD/Unit)
Table 18. Typhoid Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Typhoid Vaccine Product Type
Table 20. Date of International Manufacturers Enter into Typhoid Vaccine Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Typhoid Vaccine Sales by Type (2015-2020) (K Units)
Table 23. Global Typhoid Vaccine Sales Share by Type (2015-2020)
Table 24. Global Typhoid Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Typhoid Vaccine Revenue Share by Type (2015-2020)
Table 26. Typhoid Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Typhoid Vaccine Sales by Application (2015-2020) (K Units)
Table 28. Global Typhoid Vaccine Sales Share by Application (2015-2020)
Table 29. North America Typhoid Vaccine Sales by Country (2015-2020) (K Units)
Table 30. North America Typhoid Vaccine Sales Market Share by Country (2015-2020)
Table 31. North America Typhoid Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Typhoid Vaccine Revenue Market Share by Country (2015-2020)
Table 33. North America Typhoid Vaccine Sales by Type (2015-2020) (K Units)
Table 34. North America Typhoid Vaccine Sales Market Share by Type (2015-2020)
Table 35. North America Typhoid Vaccine Sales by Application (2015-2020) (K Units)
Table 36. North America Typhoid Vaccine Sales Market Share by Application (2015-2020)
Table 37. Europe Typhoid Vaccine Sales by Country (2015-2020) (K Units)
Table 38. Europe Typhoid Vaccine Sales Market Share by Country (2015-2020)
Table 39. Europe Typhoid Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Typhoid Vaccine Revenue Market Share by Country (2015-2020)
Table 41. Europe Typhoid Vaccine Sales by Type (2015-2020) (K Units)
Table 42. Europe Typhoid Vaccine Sales Market Share by Type (2015-2020)
Table 43. Europe Typhoid Vaccine Sales by Application (2015-2020) (K Units)
Table 44. Europe Typhoid Vaccine Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Typhoid Vaccine Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Typhoid Vaccine Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Typhoid Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Typhoid Vaccine Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Typhoid Vaccine Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Typhoid Vaccine Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Typhoid Vaccine Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Typhoid Vaccine Sales Market Share by Application (2015-2020)
Table 53. Latin America Typhoid Vaccine Sales by Country (2015-2020) (K Units)
Table 54. Latin America Typhoid Vaccine Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Typhoid Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Typhoid Vaccine Revenue Market Share by Country (2015-2020)
Table 57. Latin America Typhoid Vaccine Sales by Type (2015-2020) (K Units)
Table 58. Latin America Typhoid Vaccine Sales Market Share by Type (2015-2020)
Table 59. Latin America Typhoid Vaccine Sales by Application (2015-2020) (K Units)
Table 60. Latin America Typhoid Vaccine Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Typhoid Vaccine Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Typhoid Vaccine Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Typhoid Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Typhoid Vaccine Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Typhoid Vaccine Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Typhoid Vaccine Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Typhoid Vaccine Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Typhoid Vaccine Sales Market Share by Application (2015-2020)
Table 69. Sanofi Corporation Information
Table 70. Sanofi Description and Major Businesses
Table 71. Sanofi Typhoid Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Sanofi Product
Table 73. Sanofi Recent Development
Table 74. Merck Corporation Information
Table 75. Merck Description and Major Businesses
Table 76. Merck Typhoid Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Merck Product
Table 78. Merck Recent Development
Table 79. GlaxoSmithKline Corporation Information
Table 80. GlaxoSmithKline Description and Major Businesses
Table 81. GlaxoSmithKline Typhoid Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. GlaxoSmithKline Product
Table 83. GlaxoSmithKline Recent Development
Table 84. PaxVax Corporation Information
Table 85. PaxVax Description and Major Businesses
Table 86. PaxVax Typhoid Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. PaxVax Product
Table 88. PaxVax Recent Development
Table 89. Actiza Pharmaceutical Corporation Information
Table 90. Actiza Pharmaceutical Description and Major Businesses
Table 91. Actiza Pharmaceutical Typhoid Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Actiza Pharmaceutical Product
Table 93. Actiza Pharmaceutical Recent Development
Table 94. Merit Pharmaceuticals Corporation Information
Table 95. Merit Pharmaceuticals Description and Major Businesses
Table 96. Merit Pharmaceuticals Typhoid Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Merit Pharmaceuticals Product
Table 98. Merit Pharmaceuticals Recent Development
Table 99. Bharat Biotec Corporation Information
Table 100. Bharat Biotec Description and Major Businesses
Table 101. Bharat Biotec Typhoid Vaccine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Bharat Biotec Product
Table 103. Bharat Biotec Recent Development
Table 104. Global Typhoid Vaccine Sales Forecast by Regions (2021-2026) (K Units)
Table 105. Global Typhoid Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 106. Global Typhoid Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 107. Global Typhoid Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 108. North America: Typhoid Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 109. North America: Typhoid Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 110. Europe: Typhoid Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 111. Europe: Typhoid Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 112. Asia Pacific: Typhoid Vaccine Sales Forecast by Region (2021-2026) (K Units)
Table 113. Asia Pacific: Typhoid Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Latin America: Typhoid Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 115. Latin America: Typhoid Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Middle East and Africa: Typhoid Vaccine Sales Forecast by Country (2021-2026) (K Units)
Table 117. Middle East and Africa: Typhoid Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Market Risks
Table 121. Main Points Interviewed from Key Typhoid Vaccine Players
Table 122. Typhoid Vaccine Customers List
Table 123. Typhoid Vaccine Distributors List
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Typhoid Vaccine Product Picture
Figure 2. Global Typhoid Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Type Product Picture
Figure 4. Injection Type Product Picture
Figure 5. Global Typhoid Vaccine Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Research & Academic Laboratories
Figure 8. Pharmaceutical & Biotechnology Companies
Figure 9. Others
Figure 10. Typhoid Vaccine Report Years Considered
Figure 11. Global Typhoid Vaccine Market Size 2015-2026 (US$ Million)
Figure 12. Global Typhoid Vaccine Sales 2015-2026 (K Units)
Figure 13. Global Typhoid Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Typhoid Vaccine Sales Market Share by Region (2015-2020)
Figure 15. Global Typhoid Vaccine Sales Market Share by Region in 2019
Figure 16. Global Typhoid Vaccine Revenue Market Share by Region (2015-2020)
Figure 17. Global Typhoid Vaccine Revenue Market Share by Region in 2019
Figure 18. Global Typhoid Vaccine Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Typhoid Vaccine Revenue in 2019
Figure 20. Typhoid Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Typhoid Vaccine Sales Market Share by Type (2015-2020)
Figure 22. Global Typhoid Vaccine Sales Market Share by Type in 2019
Figure 23. Global Typhoid Vaccine Revenue Market Share by Type (2015-2020)
Figure 24. Global Typhoid Vaccine Revenue Market Share by Type in 2019
Figure 25. Global Typhoid Vaccine Market Share by Price Range (2015-2020)
Figure 26. Global Typhoid Vaccine Sales Market Share by Application (2015-2020)
Figure 27. Global Typhoid Vaccine Sales Market Share by Application in 2019
Figure 28. Global Typhoid Vaccine Revenue Market Share by Application (2015-2020)
Figure 29. Global Typhoid Vaccine Revenue Market Share by Application in 2019
Figure 30. North America Typhoid Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Typhoid Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Typhoid Vaccine Sales Market Share by Country in 2019
Figure 33. North America Typhoid Vaccine Revenue Market Share by Country in 2019
Figure 34. U.S. Typhoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Typhoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Typhoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Typhoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Typhoid Vaccine Market Share by Type in 2019
Figure 39. North America Typhoid Vaccine Market Share by Application in 2019
Figure 40. Europe Typhoid Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Typhoid Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Typhoid Vaccine Sales Market Share by Country in 2019
Figure 43. Europe Typhoid Vaccine Revenue Market Share by Country in 2019
Figure 44. Germany Typhoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Typhoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Typhoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Typhoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Typhoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Typhoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Typhoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Typhoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Typhoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Typhoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Typhoid Vaccine Market Share by Type in 2019
Figure 55. Europe Typhoid Vaccine Market Share by Application in 2019
Figure 56. Asia Pacific Typhoid Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Typhoid Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Typhoid Vaccine Sales Market Share by Region in 2019
Figure 59. Asia Pacific Typhoid Vaccine Revenue Market Share by Region in 2019
Figure 60. China Typhoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Typhoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Typhoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Typhoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Typhoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Typhoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Typhoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Typhoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Typhoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Typhoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Typhoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Typhoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Typhoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Typhoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Typhoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Typhoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Typhoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Typhoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Typhoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Typhoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Typhoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Typhoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Typhoid Vaccine Market Share by Type in 2019
Figure 83. Asia Pacific Typhoid Vaccine Market Share by Application in 2019
Figure 84. Latin America Typhoid Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Typhoid Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Typhoid Vaccine Sales Market Share by Country in 2019
Figure 87. Latin America Typhoid Vaccine Revenue Market Share by Country in 2019
Figure 88. Mexico Typhoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Typhoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Typhoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Typhoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Typhoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Typhoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Typhoid Vaccine Market Share by Type in 2019
Figure 95. Latin America Typhoid Vaccine Market Share by Application in 2019
Figure 96. Middle East and Africa Typhoid Vaccine Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Typhoid Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Typhoid Vaccine Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Typhoid Vaccine Revenue Market Share by Country in 2019
Figure 100. Turkey Typhoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Typhoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Typhoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Typhoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Typhoid Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 105. U.A.E Typhoid Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Typhoid Vaccine Market Share by Type in 2019
Figure 107. Middle East and Africa Typhoid Vaccine Market Share by Application in 2019
Figure 108. North America Typhoid Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. North America Typhoid Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Typhoid Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Europe Typhoid Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Typhoid Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Asia Pacific Typhoid Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Typhoid Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Latin America Typhoid Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Typhoid Vaccine Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Middle East and Africa Typhoid Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
アデノウイルスワクチンの世界市場（～2026年） Market Analysis and Insights: Global Adenovirus Vaccine Market The global Adenovirus Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Adenovirus Vaccine Scope and Market Size Adenovirus Vaccine market is segment…- 経口ワクチンの世界市場（～2026年） Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery …
- 獣医クロストリジウムワクチンの世界市場（～2026年） Market Analysis and Insights: Global Veterinary Clostridium Vaccine Market The global Veterinary Clostridium Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Veterinary Clostridium Vaccine Scope and Market Size …
- 子宮頸がんワクチンの世界市場（～2026年） Market Analysis and Insights: Global Cervical Cancer Vaccine Market The global Cervical Cancer Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cervical Cancer Vaccine Scope and Market Size Cervical Cancer Vacci…
- 結核ワクチン治療の世界市場（～2026年） Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at …